Trial Profile
Long-term retrospective study of Tocilizumab in patients with Rheumatoid Arthritis who are refractory to DMARDs, anti-TNF and rituximab.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Aug 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 23 Aug 2016 New trial record